Axel Nordenskjöld

30PUBLICATIONS
37CO-AUTHORS
Infant and child healthMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 29, 2026
Age of Onset of first depressive episode requiring hospitalisation, Clinical Characteristics, and Response to Electroconvulsive Therapy.

|Dec 17, 2025
Diagnostic Conversion From Psychotic Unipolar Depression to Bipolar and Psychotic Disorders: A Swedish Registry-Based Study.

Ahmed Al-Wandi, Mikael Landén, Axel Nordenskjöld

|Nov 19, 2025
Real-world analysis of pharmacological treatments to prevent relapse after electroconvulsive therapy for major depressive disorder: A nationwide cohort study.

Alexander Kronsell, Axel Nordenskjöld, Robert Bodén

|Feb 16, 2025
Recasting the role of electroconvulsive therapy and the electroconvulsive therapy practitioner: For severe illness, not necessarily treatment-resistant depression.

Randall T Espinoza, Charles H Kellner, Alexander Sartorius

|Oct 03, 2024
Blood biomarkers of neuronal injury and astrocytic reactivity in electroconvulsive therapy.

Robert Sigström, Andreas Göteson, Erik Joas

|May 28, 2024
Electroconvulsive therapy in the maintenance phase of psychotic unipolar depression.

Ahmed Al-Wandi, Mikael Landén, Axel Nordenskjöld

Pageof 5

Frequent Collaborators

7 joint publications

Mikael Landén

4 joint publications

Ahmed Al-Wandi

4 joint publications

Pouya Movahed Rad

3 joint publications

Charles H Kellner